Compare TGL & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGL | CELZ |
|---|---|---|
| Founded | 2020 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8M | 6.6M |
| IPO Year | 2022 | 2008 |
| Metric | TGL | CELZ |
|---|---|---|
| Price | $3.73 | $1.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 24.6K | 13.9K |
| Earning Date | 02-24-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.33 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,330,557.00 | $11,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.22 |
| 52 Week Low | $0.04 | $1.50 |
| 52 Week High | $58.00 | $6.25 |
| Indicator | TGL | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 37.05 | 49.16 |
| Support Level | $0.89 | $1.76 |
| Resistance Level | $9.45 | $1.99 |
| Average True Range (ATR) | 0.27 | 0.08 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 5.74 | 56.58 |
Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: payment processing and e-commerce operation in its ZCITY platform, and customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.